Intended Use

ART-Plan is a software intended to be used by trained clinicians familiar with radiation therapy to aid radiotherapy treatment planning involving visualization, registration, segmentation, synthetic CT generation, dose computation, and adaptation decision-making.

Technology

ART-Plan integrates AI-driven automatic delineation (deep learning-based segmentation), multimodal rigid and deformable image registration, synthetic CT generation from MR and CBCT, and dose computation within a software platform accessible via standard web browsers. The software supports manual and semi-automatic contouring, visualization and evaluation of fused images, and assists in offline adaptation decision-making for radiotherapy.

Performance

ART-Plan's modules have been validated through extensive clinical and bench testing including qualitative and quantitative evaluation of automatic segmentation, image registration, synthetic CT generation, and dose calculation using metrics like Dice Similarity Coefficient (DSC), gamma passing rates, and clinical expert assessments. Testing demonstrated safety, effectiveness, non-inferiority to predicate devices, and no significant bias across demographic subgroups.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    8/16/2023

    4 months
  • 2

    FDA Approval

    12/22/2023

Other devices from TheraPanacea

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.